Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
42.58
+1.94 (4.76%)
Mar 14, 2025, 12:31 PM EDT - Market open
Guardant Health Analyst Ratings
Total Analysts
20
Consensus Rating
Strong Buy
Price Target
$48.40
Upside
+13.68%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $42 → $52 | Buy | Maintains | $42 → $52 | +22.14% | Mar 6, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $34 → $50 | Buy | Maintains | $34 → $50 | +17.44% | Feb 26, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $56 | Strong Buy | Reiterates | $56 | +31.53% | Feb 24, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $47 → $52 | Buy | Maintains | $47 → $52 | +22.14% | Feb 24, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $42 → $60 | Strong Buy | Maintains | $42 → $60 | +40.93% | Feb 24, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $49 → $56 | Strong Buy | Maintains | $49 → $56 | +31.53% | Feb 21, 2025 |
| Raymond James | Raymond James | Buy Reiterates $39 → $59 | Buy | Reiterates | $39 → $59 | +38.58% | Feb 21, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $50 → $55 | Buy | Maintains | $50 → $55 | +29.18% | Feb 21, 2025 |
| Stifel | Stifel | Strong Buy Maintains $45 → $53 | Strong Buy | Maintains | $45 → $53 | +24.49% | Feb 21, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $36 → $49 | Strong Buy | Maintains | $36 → $49 | +15.09% | Jan 28, 2025 |
| Barclays | Barclays | Buy Initiates $60 | Buy | Initiates | $60 | +40.93% | Jan 23, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Jan 22, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $48 → $50 | Buy | Maintains | $48 → $50 | +17.44% | Nov 7, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $32 → $36 | Strong Buy | Maintains | $32 → $36 | -15.44% | Nov 7, 2024 |
| Bernstein | Bernstein | Buy Maintains $40 → $35 | Buy | Maintains | $40 → $35 | -17.79% | Oct 30, 2024 |
| UBS | UBS | Strong Buy Maintains $32 → $40 | Strong Buy | Maintains | $32 → $40 | -6.05% | Aug 21, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.